REVIEW ARTICLE
Year : 2018  |  Volume : 9  |  Issue : 3  |  Page : 131-146

Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review


1 Department of Experimental Medicine, Campania Pharmacovigilance and Pharmacoepidemiology Regional Centre, Section of Pharmacology “L. Donatelli”, University of Campania “L. Vanvitelli”; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
2 Department of Clinical and Experimental Medicine “Magrassi-Lanzara”, Section of Radiology and Radiotherapy, University of Campania “L. Vanvitelli”, Naples, Italy
3 Department of Experimental Medicine, Campania Pharmacovigilance and Pharmacoepidemiology Regional Centre, Section of Pharmacology “L. Donatelli”, University of Campania “L. Vanvitelli”, Copenhagen, Denmark
4 Department of Experimental Medicine, University of Campania “L. Vanvitelli”, Naples, Italy

Correspondence Address:
Maurizio Sessa
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark; Department of Experimental Medicine, Campania Pharmacovigilance and Pharmacoepidemiology Regional Centre, Section of Pharmacology “L. Donatelli”, University of Campania “L. Vanvitelli”, Via Santa Maria Di Costantinopoli 16, 80138 Naples, Italy

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpp.JPP_92_18

Rights and Permissions

The aim of this study was to investigate the scientific contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades. Ovid Embase, Ovid MEDLINE, Web of Science, and Cochrane Methodology Register were used as data sources to identify Italian descriptive studies, observational studies, meta-analyses, and clinical trials assessing contrast media-induced nonrenal adverse drug reactions as a safety outcome. The population of interest was men and women exposed to a contrast medium. Between 1990 and 2017, 24 original articles investigating contrast-induced nonrenal adverse drug reactions were identified. The cohort study was the most representative study design (10/24; 41.7%). The 24 studies were conducted mainly as monocenter studies (14/24; 58.3%) and without receiving funding (17/24; 70.8%). Seventeen out of 24 studies provided a level of evidence ranging from III-2 (11/24; 45.8%) to IV (6/24; 25.0%) on a Merlin scale. In total, 14 of 24 (58.3%) studies were published in a scientific journal ranked in the first quartile of their subject area. The 24 original articles mainly focused on adverse drug reactions already observed during clinical trials (i.e., idiosyncratic systemic reactions). In conclusion, during the last three decades and a burst was not observed in the Italian clinical research investigating contrast-induced nonrenal adverse drug reactions. High-quality clinical research is needed especially for procedures to prevent the onset of the aforementioned events, to identify risk factors, to minimize the risk of their occurrence, and to optimize their related prognosis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed225    
    Printed34    
    Emailed0    
    PDF Downloaded80    
    Comments [Add]    

Recommend this journal